Advanced Enzyme Technologies Ltd
BSE:540025
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Advanced Enzyme Technologies Ltd
BSE:540025
|
IN |
|
3
|
3M Co
SWB:MMM
|
US |
|
B3 Consulting Group AB (publ)
LSE:0RL1
|
SE |
|
ME Therapeutics Holdings Inc
OTC:METXF
|
CA |
|
Telefonica SA
MAD:TEF
|
ES |
|
C
|
Clinuvel Pharmaceuticals Ltd
XBER:UR9
|
AU |
|
S
|
Singapore Airlines Ltd
DUS:SIA1
|
SG |
|
A
|
Altea Green Power SpA
MIL:AGP
|
IT |
|
Sumber Alfaria Trijaya Tbk PT
OTC:PSBAF
|
ID |
|
T
|
Tourmaline Oil Corp
OTC:TRMLF
|
CA |
|
Lordstown Motors Corp
OTC:NRDE
|
US |
|
ARC Resources Ltd
TSX:ARX
|
CA |
|
Persistent Systems Ltd
BSE:533179
|
IN |
|
Caseys General Stores Inc
NASDAQ:CASY
|
US |
|
H
|
Huntington Bancshares Inc
DUS:HU3
|
US |
|
Westpac Banking Corp
ASX:WBC
|
AU |
|
CAE Inc
TSX:CAE
|
CA |
|
CESC Ltd
BSE:500084
|
IN |
|
F
|
Frequency Electronics Inc
F:98K
|
US |
|
S
|
Synectics PLC
XBER:RNR
|
UK |
|
Inspecs Group PLC
LSE:SPEC
|
UK |
|
Entech SA
PAR:ALESE
|
FR |
|
B
|
Brown & Brown Inc
XMUN:BTW
|
US |
|
MTY Food Group Inc
TSX:MTY
|
CA |
Wall St Price Targets
ADVENZYMES Price Targets Summary
Advanced Enzyme Technologies Ltd
According to Wall Street analysts, the average 1-year price target for ADVENZYMES is 376.58 INR with a low forecast of 372.89 INR and a high forecast of 387.66 INR.
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is ADVENZYMES's stock price target?
Price Target
376.58
INR
According to Wall Street analysts, the average 1-year price target for ADVENZYMES is 376.58 INR with a low forecast of 372.89 INR and a high forecast of 387.66 INR.
What is the Revenue forecast for Advanced Enzyme Technologies Ltd?
Projected CAGR
17%
Over the last 13 years, the compound annual growth rate for Revenue has been 11%. The projected CAGR for the next 3 years is 17%.
What is the Operating Income forecast for Advanced Enzyme Technologies Ltd?
Projected CAGR
17%
Over the last 13 years, the compound annual growth rate for Operating Income has been 8%. The projected CAGR for the next 3 years is 17%.
What is the Net Income forecast for Advanced Enzyme Technologies Ltd?
Projected CAGR
17%
Over the last 13 years, the compound annual growth rate for Net Income has been 11%. The projected CAGR for the next 3 years is 17%.
